FdaApplication
NDA 021924
Identifiers
- fda_app_no: NDA021924
Properties
| Property | Value |
|---|---|
| applicant_name | IBSA INSTITUT BIOCHIMIQUE SA |
| application_type | NDA |
| approval_date | 2006-10-13 |
Products (15)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TIROSINT | LEVOTHYROXINE SODIUM | 0.112MG | CAPSULE;ORAL |
| TIROSINT | LEVOTHYROXINE SODIUM | 0.125MG | CAPSULE;ORAL |
| TIROSINT | LEVOTHYROXINE SODIUM | 0.175MG | CAPSULE;ORAL |
| TIROSINT | LEVOTHYROXINE SODIUM | 0.15MG | CAPSULE;ORAL |
| TIROSINT | LEVOTHYROXINE SODIUM | 0.044MG | CAPSULE;ORAL |
| TIROSINT | LEVOTHYROXINE SODIUM | 0.0625MG | CAPSULE;ORAL |
| TIROSINT | LEVOTHYROXINE SODIUM | 0.088MG | CAPSULE;ORAL |
| TIROSINT | LEVOTHYROXINE SODIUM | 0.075MG | CAPSULE;ORAL |
| TIROSINT | LEVOTHYROXINE SODIUM | 0.0375MG | CAPSULE;ORAL |
| TIROSINT | LEVOTHYROXINE SODIUM | 0.013MG | CAPSULE;ORAL |
| TIROSINT | LEVOTHYROXINE SODIUM | 0.025MG | CAPSULE;ORAL |
| TIROSINT | LEVOTHYROXINE SODIUM | 0.1MG | CAPSULE;ORAL |
| TIROSINT | LEVOTHYROXINE SODIUM | 0.137MG | CAPSULE;ORAL |
| TIROSINT | LEVOTHYROXINE SODIUM | 0.05MG | CAPSULE;ORAL |
| TIROSINT | LEVOTHYROXINE SODIUM | 0.2MG | CAPSULE;ORAL |
15 products